Hair loss in an HIV-1 infected woman receiving lopinavir plus ritonavirtherapy as first line HAART

Dermatology Online Journal

Volumn 9, Issue 5, 2003, Pages 184-185

  Bongiovanni, Marco ^a   Chiesa, Elisabetta ^a   Monforte, Antonella D'Arminio ^a   Bini, Teresa ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; COTRIMOXAZOLE; INDINAVIR; LAMIVUDINE; LOPINAVIR PLUS RITONAVIR; NELFINAVIR; RNA; STAVUDINE;

ADULT; ARTICLE; CASE REPORT; DISEASE COURSE; FEMALE; HAIR GROWTH; HAIR LOSS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGICAL PARAMETERS; PNEUMOCYSTIS PNEUMONIA; TIME; TREATMENT OUTCOME; TREATMENT WITHDRAWAL;

EID: 3142618425     PISSN: 10872108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (2)

1. Calista D, Boschini A. Cutaneous side effects induced by indinavir. Eur J Dermatol. 2000 Jun;10(4):292-6. PubMed
2. Toma E, Devost D, Chow LN, Bhat PV. HIV-protease inhibitors alter retinoic acid synthesis. AIDS. 2001 Oct 19;15(15):1979-84. PubMed